As hay fever season sweeps across Britain, millions are turning to familiar allergy medications to tackle sneezing, itchy eyes and runny noses. However, some experts have voiced concerns regarding one widely used medicine and its potential connection to a serious long-term health condition.

The medication in question is Benadryl, a popular antihistamine available in chemists and supermarkets nationwide. While many use it safely for short-term relief, studies have indicated that extended use of certain ingredients may be linked to a substantially elevated risk of dementia in later years.

According to the NHS, antihistamines such as Benadryl can be used to treat allergies, insect bites and hay fever symptoms. Some types can also cause drowsiness, with side effects including dry mouth, dizziness and difficulty concentrating.

The worry focuses on older-generation antihistamines containing anticholinergic drugs, which function by blocking acetylcholine – a chemical messenger involved in memory and learning. Benadryl products sold in the US commonly contain diphenhydramine, while some UK Benadryl products contain acrivastine or cetirizine, depending on the formulation.

Research highlighted by Harvard Health found people who used strong anticholinergic drugs for three years or more had a 54 per cent higher dementia risk than those who used them for three months or less. The study, published in JAMA Internal Medicine, examined nearly 3,500 adults aged 65 and older.

Harvard Health has revealed that diphenhydramine — the active ingredient found in certain Benadryl products — is amongst the anticholinergic medicines associated with a heightened risk. Researchers were keen to emphasise that the findings demonstrate a link rather than conclusive evidence that the drugs directly trigger dementia.

According to the NHS, elderly patients may be particularly susceptible to the effects of antihistamines, with side effects including confusion and drowsiness. Health guidance further cautions that certain antihistamines can interact with other medications or aggravate specific medical conditions, amongst them glaucoma and urinary retention problems.

A separate Harvard Health report noted that anticholinergic drugs may impact the brain by blocking signals associated with cognition and memory. Experts also warned that taking multiple anticholinergic medicines simultaneously could heighten the risk further.

The Alzheimer’s Society has stated that further research is required to fully establish the relationship between anticholinergic drugs and dementia. Nevertheless, it recommends that anyone concerned about the side effects of their medication consult a GP or pharmacist prior to making any alterations.

Health professionals stress that patients should never abruptly discontinue prescribed medication without first seeking medical advice. Those who require regular allergy relief may wish to explore newer non-drowsy antihistamines or alternative treatment options with a qualified healthcare professional.